GlassScriptPhysician profile
Emily Philpott
NPI 1871100586
$2,820.50
in general payments reported to CMS, 2019-2025
26 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $937 · 2023: $690 · 2024: $767 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.56 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $665.81 | 2022-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $468.43 | 2023-2025 | Xtampza, Belbuca |
| Janssen Biotech, INC. | $356.52 | 2022-2023 | |
| Boston Scientific Corporation | $269.80 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $144.37 | 2022-2025 | |
| Myovant Sciences INC. | $133.60 | 2022 | |
| Laborie Medical Technologies Corp. | $114.81 | 2022-2023 | |
| Urovant Sciences INC | $84.85 | 2022 | |
| Sumitomo Pharma America, INC. | $76.78 | 2023 | Gemtesa, Orgovyx |
| Vertex Pharmaceuticals Incorporated | $52.52 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.12 | 2022 | |
| 180 Medical, INC. | $45.67 | 2022-2023 | Gentlecath |
| Pfizer INC. | $44.36 | 2022-2023 | |
| Curonix LLC | $41.81 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Hikma Pharmaceuticals USA | $38.33 | 2022-2024 | Kloxxado |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $37.70 | 2023 | Lyvispah |
| Lundbeck LLC | $25.11 | 2022 | |
| Redhill Biopharma INC. | $23.68 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $22.43 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $22.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.80 | 2022 | |
| Allergan, INC. | $18.12 | 2022 | |
| Protega Pharmaceutials INC | $17.87 | 2025 | Roxybond |
| Amgen INC. | $17.70 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.44 | 2024 | Horizant |
| Abc Home Medical Supply, INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Philpott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.